DE69113205D1 - Transdermales therapeutisches System. - Google Patents

Transdermales therapeutisches System.

Info

Publication number
DE69113205D1
DE69113205D1 DE69113205T DE69113205T DE69113205D1 DE 69113205 D1 DE69113205 D1 DE 69113205D1 DE 69113205 T DE69113205 T DE 69113205T DE 69113205 T DE69113205 T DE 69113205T DE 69113205 D1 DE69113205 D1 DE 69113205D1
Authority
DE
Germany
Prior art keywords
therapeutic system
transdermal therapeutic
transdermal
therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69113205T
Other languages
English (en)
Other versions
DE69113205T2 (de
Inventor
Yoshiaki Yano
Kazuyuki Takeo
Takayoshi Hidaka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kanegafuchi Chemical Industry Co Ltd
Original Assignee
Kanegafuchi Chemical Industry Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kanegafuchi Chemical Industry Co Ltd filed Critical Kanegafuchi Chemical Industry Co Ltd
Application granted granted Critical
Publication of DE69113205D1 publication Critical patent/DE69113205D1/de
Publication of DE69113205T2 publication Critical patent/DE69113205T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7076—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/58—Adhesives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Botany (AREA)
  • Hematology (AREA)
  • Materials Engineering (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
DE69113205T 1990-10-22 1991-10-21 Transdermales therapeutisches System. Expired - Fee Related DE69113205T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP28474590 1990-10-22
JP28925990 1990-10-25

Publications (2)

Publication Number Publication Date
DE69113205D1 true DE69113205D1 (de) 1995-10-26
DE69113205T2 DE69113205T2 (de) 1996-02-22

Family

ID=26555594

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69113205T Expired - Fee Related DE69113205T2 (de) 1990-10-22 1991-10-21 Transdermales therapeutisches System.

Country Status (4)

Country Link
US (1) US5556636A (de)
EP (1) EP0482554B1 (de)
CA (1) CA2053462A1 (de)
DE (1) DE69113205T2 (de)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2735024B1 (fr) * 1995-06-08 1997-11-28 Sanofi Sa Dispositif d'administration cutanee d'un produit medicamenteux ou cosmetique.
ES2239372T3 (es) * 1997-07-17 2005-09-16 Nitto Denko Corporation Lamina adhesiva medica y su produccion.
US6146656A (en) * 1998-01-22 2000-11-14 Nitto Denko Corporation Percutaneous absorption preparation
US20040018237A1 (en) 2002-05-31 2004-01-29 Perricone Nicholas V. Topical drug delivery using phosphatidylcholine
US20040086551A1 (en) * 2002-10-30 2004-05-06 Miller Kenneth J. Fentanyl suspension-based silicone adhesive formulations and devices for transdermal delivery of fentanyl
US7651485B2 (en) * 2002-11-27 2010-01-26 Bristol-Myers Squibb Company Ostomy pouch adhesives such as polysiloxanes that are resistant to stomal effluent
WO2004100926A2 (en) * 2003-05-13 2004-11-25 Medtronic, Inc. Delivery of agents using hydrolyzable leaving groups
JP4593471B2 (ja) * 2003-10-20 2010-12-08 久光製薬株式会社 皮膚外用貼付剤
US20070172518A1 (en) 2004-03-12 2007-07-26 Dow Corning Corporation Method of making silicone pressure sensitive adhesives for delivering hydrophilic drugs
DK1737504T3 (da) * 2004-04-08 2010-07-19 Dow Corning Silikonehudpåføringsgel
EP1793811A1 (de) * 2004-09-07 2007-06-13 Dow Corning Corporation Silikon-klebeformulierung mit einem antisperspirans
US7888422B2 (en) 2005-11-09 2011-02-15 Mylan Technologies Inc. Long-wearing removable pressure sensitive adhesive
GB2443161B (en) * 2006-10-28 2011-03-23 Nupharm Lab Ltd Clobetasol spray
US7976951B2 (en) 2006-11-14 2011-07-12 Momentive Performance Materials Inc. Laminate containing an adhesive-forming composition
US7829116B2 (en) 2006-11-14 2010-11-09 Momentive Performance Materials Inc. Adhesive-forming composition and blend of adhesives obtained therefrom
US9017301B2 (en) * 2007-09-04 2015-04-28 Mylan Technologies, Inc. Transdermal drug delivery systems comprising a coated release liner
EP2552245B1 (de) 2010-03-26 2018-11-14 Philip Morris Products S.A. Hemmung von sensorischer irritation während des konsums von nicht rauchbaren tabakprodukten
US8952038B2 (en) 2010-03-26 2015-02-10 Philip Morris Usa Inc. Inhibition of undesired sensory effects by the compound camphor
JP2014508166A (ja) 2011-03-17 2014-04-03 トランスダーマル バイオテクノロジ インコーポレーテッド 局所的一酸化窒素システム及びその使用方法
US8871256B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Methods and systems for treatment of inflammatory diseases with nitric oxide
US8871254B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Systems and methods for treatment of acne vulgaris and other conditions with a topical nitric oxide delivery system
US8871258B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Treatment and prevention of learning and memory disorders
US8871260B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Methods and compositions for muscular and neuromuscular diseases
US8871261B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Cancer treatments and compositions for use thereof
US8871255B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Treatment of skin and soft tissue infection with nitric oxide
US8871262B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Compositions and methods for treatment of osteoporosis and other indications
US8871257B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Prevention and treatment of cardiovascular diseases using systems and methods for transdermal nitric oxide delivery
US8871259B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Techniques and systems for treatment of neuropathic pain and other indications
US9295636B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Wound healing using topical systems and methods
US9393265B2 (en) 2013-03-13 2016-07-19 Transdermal Biotechnology, Inc. Wound healing using topical systems and methods
US9339457B2 (en) 2013-03-13 2016-05-17 Transdermal Biotechnology, Inc. Cardiovascular disease treatment and prevention
US9241899B2 (en) 2013-03-13 2016-01-26 Transdermal Biotechnology, Inc. Topical systems and methods for treating sexual dysfunction
US9295647B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Systems and methods for delivery of peptides
US9320758B2 (en) 2013-03-13 2016-04-26 Transdermal Biotechnology, Inc. Brain and neural treatments comprising peptides and other compositions
US9724419B2 (en) 2013-03-13 2017-08-08 Transdermal Biotechnology, Inc. Peptide systems and methods for metabolic conditions
US9849160B2 (en) 2013-03-13 2017-12-26 Transdermal Biotechnology, Inc. Methods and systems for treating or preventing cancer
US20140271938A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Systems and methods for delivery of peptides
US9687520B2 (en) 2013-03-13 2017-06-27 Transdermal Biotechnology, Inc. Memory or learning improvement using peptide and other compositions
US9314433B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Methods and systems for treating or preventing cancer
US20140271937A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Brain and neural treatments comprising peptides and other compositions
US9314422B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Peptide systems and methods for metabolic conditions
US9320706B2 (en) 2013-03-13 2016-04-26 Transdermal Biotechnology, Inc. Immune modulation using peptides and other compositions
US9314423B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Hair treatment systems and methods using peptides and other compositions
US9750787B2 (en) 2013-03-13 2017-09-05 Transdermal Biotechnology, Inc. Memory or learning improvement using peptide and other compositions
US9295637B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Compositions and methods for affecting mood states
US9387159B2 (en) 2013-03-13 2016-07-12 Transdermal Biotechnology, Inc. Treatment of skin, including aging skin, to improve appearance
US9314417B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Treatment of skin, including aging skin, to improve appearance
US9393264B2 (en) 2013-03-13 2016-07-19 Transdermal Biotechnology, Inc. Immune modulation using peptides and other compositions
US20140271731A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Cardiovascular disease treatment and prevention
US11686094B2 (en) 2013-03-15 2023-06-27 Holcim Technology Ltd Bonding adhesive and adhered roofing systems prepared using the same
US11160764B2 (en) * 2015-11-02 2021-11-02 Medherant Limited Drug delivery composition containing silyl polymers
WO2017223173A1 (en) 2016-06-21 2017-12-28 Bridgestone Americas Tire Operations, Llc Methods for treating inner liner surface, inner liners resulting therefrom and tires containing such inner liners
BR112018077027B1 (pt) 2016-06-30 2023-03-14 Bridgestone Americas Tire Operations, Llc Método para tratamento de um forro interno curado para um pneu; método para produzir um pneu e pneu curado
JP6848062B2 (ja) 2016-12-15 2021-03-24 ブリヂストン アメリカズ タイヤ オペレーションズ、 エルエルシー 硬化したインナーライナー上にポリマー含有コーティングを生成する方法、かかるインナーライナーを含むタイヤを製造する方法、及びかかるインナーライナーを含むタイヤ
JP6961697B2 (ja) 2016-12-15 2021-11-05 ブリヂストン アメリカズ タイヤ オペレーションズ、 エルエルシー バリアを有するシーラント層、それを含有するタイヤ、及び関連するプロセス
US11697306B2 (en) 2016-12-15 2023-07-11 Bridgestone Americas Tire Operations, Llc Sealant-containing tire and related processes
DE102019120403A1 (de) * 2019-07-29 2021-02-04 Lts Lohmann Therapie-Systeme Ag Verfahren zur Herstellung von Haftklebemassen zur Verwendung in einem transdermalen therapeutischen System

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5971377A (ja) * 1982-10-15 1984-04-23 Kanegafuchi Chem Ind Co Ltd 粘着剤組成物
JPS6160771A (ja) * 1984-08-31 1986-03-28 Kanegafuchi Chem Ind Co Ltd 粘着剤組成物
US4655767A (en) * 1984-10-29 1987-04-07 Dow Corning Corporation Transdermal drug delivery devices with amine-resistant silicone adhesives
JPS6248785A (ja) * 1985-08-26 1987-03-03 Sekisui Chem Co Ltd 粘着テ−プもしくはフイルム
JPH0623370B2 (ja) * 1986-03-25 1994-03-30 日本石油株式会社 粘着剤組成物
JPH0751515B2 (ja) * 1986-09-10 1995-06-05 明治製菓株式会社 経皮吸収製剤
JPH0794394B2 (ja) * 1986-12-24 1995-10-11 前田薬品工業株式会社 消炎鎮痛外用貼付剤

Also Published As

Publication number Publication date
CA2053462A1 (en) 1992-04-23
DE69113205T2 (de) 1996-02-22
EP0482554A3 (en) 1993-02-03
US5556636A (en) 1996-09-17
EP0482554B1 (de) 1995-09-20
EP0482554A2 (de) 1992-04-29

Similar Documents

Publication Publication Date Title
DE69113205D1 (de) Transdermales therapeutisches System.
DE68921798D1 (de) Therapeutische Nuleoside.
FI903656A0 (fi) Terapeutiska kinuklidinfoereningar.
FI906367A (fi) Terapeutiska nukleosider.
FI913899A0 (fi) Terapeutiska aerosolblandningar.
FI894688A0 (fi) Flytande oralt tagbart terapeutiskt system.
FI883757A (fi) Terapeutiska nukleosider.
FI881651A0 (fi) Terapeutiska nukleosider.
FI875098A0 (fi) Transdermalt terapeutiskt system.
FI904854A0 (fi) Terapeutiska nukleosider.
NO911429L (no) Stoffbehandling.
FI893897A (fi) Terapeutiska nukleosider.
FI930674A (fi) Terapeutiska aemnen
NO911430D0 (no) Stoffbehandlingsmetode.
FI923486A0 (fi) Terapeutiska aemnen.
FI881216A0 (fi) Terapeutiska nukleosider.
FI894321A0 (fi) Terapeutiska aemnen.
FI931071A0 (fi) Terapeutiska aemnen
FI910753A0 (fi) Terapeutiska nukleocider.
FI920701A0 (fi) Anordning foer terapeutisk tryck- behandling.
FI923528A (fi) Terapeutiska aemnen.
ES1013656Y (es) Dispositivo terapeutico.
FI912852A0 (fi) Terapeutiska dekapeptider.
NO901574L (no) Terapeutiske midler.
NO901573L (no) Terapeutiske midler.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee